Trust Company of Vermont’s Puma Biotechnology PBYI Stock Holding History

Trust Company of Vermont’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$1K	–	792
2021 Q1	$1K	Hold	100	–	–	﹤0.01%	743
2020 Q4	$1K	Hold	100	–	–	﹤0.01%	742
2020 Q3	$1K	Hold	100	–	–	﹤0.01%	733
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	752
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	853
2019 Q4	$1K	Hold	100	–	–	﹤0.01%	907
2019 Q3	$1K	Hold	100	–	–	﹤0.01%	974
2019 Q2	$1K	Hold	100	–	–	﹤0.01%	1000
2019 Q1	$4K	Hold	100	–	–	﹤0.01%	822
2018 Q4	$2K	Sell	100 -100	-50%	-$3K	﹤0.01%	933
2018 Q3	$10K	Hold	200	–	–	﹤0.01%	815
2018 Q2	$12K	Hold	200	–	–	﹤0.01%	799
2018 Q1	$14K	Buy	200 +100	+100%	+$7.49K	﹤0.01%	702
2017 Q4	$10K	Buy	+100	New	+$11.2K	﹤0.01%	761

Other funds holding PBYI

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Trust Company of Vermont's PBYI Position: Q2 2021 in Review

Trust Company of Vermont sold out of Puma Biotechnology (PBYI) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Trust Company of Vermont first reported a position in PBYI in Q4 2017 and held it in 14 quarters. The position peaked at $14K in Q1 2018. 120 funds tracked by Wall St. Rank hold PBYI as of Q2 2021.

Trust Company of Vermont reported no remaining Puma Biotechnology position as of Q2 2021 after selling out during the quarter.
Trust Company of Vermont sold 100 Puma Biotechnology shares in Q2 2021, an estimated $1K.
Trust Company of Vermont first reported a position in Puma Biotechnology in Q4 2017 and held it in 14 quarters.
Trust Company of Vermont's Puma Biotechnology position peaked at $14K in Q1 2018.
120 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2021.

Based on Trust Company of Vermont's 13F filing for Q2 2021, filed 15 Jul 2021.